Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG) (Q28362951)
scientific article
Language:
(P31) (Q13442814)
(P304) 1036-42
(P407) (Q1860)
(P433) 8
(P478) 84
(P577) Friday, April 20, 2001
(P921) (Q42824827)
(Q6934595)
(Q194908)
(Q18975855)
(Q416975)
(P1433) (Q326309)
(P1476) "Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)" (language: en)
(P2093) A Hauschild
C Garbe
W Stolz
U Ellwanger
S Seiter
R Dummer
S Ugurel
G Sebastian
D Nashan
R Linse
W Achtelik
P Mohr
R Kaufmann
M Fey
J Ulrich
W Tilgen
(P2860) (Q28378420)
(Q29619885)
(Q36115587)
(Q34747181)
(Q34418926)
(Q34371245)
(Q33490320)
(Q40761192)
(Q41703695)
(Q48261802)
(Q47880534)
(Q48469829)
(Q44191317)
(Q56891369)
(Q48299996)
(Q48017149)
(Q73270056)
(Q70313347)
(Q68773103)
(Q67903784)
(Q72503289)
(Q73494797)
(Q74463785)
(Q73181804)
other details